Page last updated: 2024-09-03

lysyl-aspartyl-glutamyl-leucine and Carcinoma, Lewis Lung

lysyl-aspartyl-glutamyl-leucine has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Björndahl, M; Cao, R; Cao, Y; Eriksson, A1

Other Studies

1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Carcinoma, Lewis Lung

ArticleYear
Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
    Circulation research, 2004, Jun-11, Volume: 94, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Assay; Carcinoma, Lewis Lung; Chemotaxis; Dimerization; Endoplasmic Reticulum; Endothelial Cells; Female; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Placenta Growth Factor; Pregnancy Proteins; Protein Sorting Signals; Recombinant Fusion Proteins; Retroviridae; Sus scrofa; Transduction, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2004